surmount-1 tirzepatide weight loss nondiabetic SURMOUNT-1: In an RCT, adults with obesity treated with weekly had major over 72 weeks. #ADA2022 https://t.co/X2RrvYxzsV SURMOUNT‐1 study design. This is

For many people, this was a significant change, often combined with improved blood sugar control

Storage, stability, and handling Compounded tirzepatide with B6 requires proper storage to maintain potency and safety

Nevertheless, given its novelty, further investigation is required to gain a comprehensive understanding of its potential adverse effects [10]

Killick, R., Fearnhead, P

Sources: Serum Zinc Concentration in Patients with Alopecia Areata (2023) National Library of Medicine (accessed 12 September 2025) Stress-Related Hair Loss Among the General Population in Al Majma'ah, Saudi Arabia: A Cross-Sectional Study (2023) Cureus (accessed 12 September 2025) Telogen effluvium (2023) British Association of Dermatology (accessed 12 September 2025) Telogen effluvium (hair shedding) (2019) DermNet (accessed 12 September 2025) Telogen effluvium: Symptoms, treatment, and recovery (2024) Medical News Today (accessed 12 September 2025) Tirzepatide Once Weekly for the Treatment of Obesity (2022) New England Journal of Medicine (accessed 12 September 2025) The Role of Vitamins and Minerals in Hair Loss: A Review (2018) Dermatology and Therapy (accessed 12 September 2025) Treatment of insulin resistance with tirzepatide leading to improvement of hair loss (2024) American Academy of Dermatology (accessed 12 September 2025)